Table 3 The effects of palmvitee supplementation on lymphocyte proliferative presented as stimulation index (S.I.) after induction with mitogen, PHA and Con A in nonsmokers and smokers
Weeks | Con A (S.I) | |||
|---|---|---|---|---|
| Â | Non-smokers | Smokers | ||
|  | Placebo, n = 27 | Palmvitee, n = 29 | Placebo, n = 28 | Palmvitee, n = 30 |
0 | 49.77 ± 36.42 | 59.17 ± 40.10 | 69.21 ± 41.11 | 52.72 ± 30.00 |
12 | 48.19 ± 28.62 | 51.03 ± 28.78 | 47.70 ± 29.73 | 59.50 ± 34.18 |
24 | 46.92 ± 23.64 | 55.10 ± 27.23 | 42.21 ± 26.59 | 42.93 ± 31.75 |
| Â | PHA (S.I) | |||
0 | 66.72 ± 48.82 | 73.97 ± 38.35 | 91.96 ± 62.15 | 73.45 ± 53.44 |
12 | 70.59 ± 39.43 | 72.14 ± 28.88 | 65.74 ± 34.69 | 75.27 ± 35.85 |
24 | 69.15 ± 28.32 | 86.41 ± 41.53 | 69.39 ± 38.07 | 77.10 ± 59.44 |